6-溴-1-甲基-1H-吲唑-3-胺 | 1214899-85-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 中文名称: 6-溴-1-甲基-1H-吲唑-3-胺
• 中文别名: 6-溴-1-甲基-1h-吲唑-3-胺
• 英文名称: 6-bromo-1-methyl-1H-indazol-3-amine
• 英文别名: 6-bromo-1-methylindazol-3-amine；3-amino-6-bromo-1-methyl-1H-indazole
• CAS: 1214899-85-0
• 化学式: C₈H₈BrN₃
• 分子量: 226.076
• InChiKey: SJCNMXPRXAGVMK-UHFFFAOYSA-N

物化性质

• 沸点：
  378.4±22.0 °C(Predicted)
• 密度：
  1.76±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  43.8
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Bromo-1-methyl-1h-indazol-3-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Bromo-1-methyl-1h-indazol-3-amine
CAS number: 1214899-85-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H8BrN3
Molecular weight: 226.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-溴-1-甲基-1H-吲唑-3-胺 在 盐酸 、 (E)-acetaldoxime 、 乳酸 、 iridium(III) chloride 、 二(三叔丁基膦)钯 、 水 、 sodium acetate 、 苄基三甲基氢氧化铵 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 sodium t-butanolate 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二甲基亚砜 、 甲苯 、 乙腈 为溶剂， 反应 201.75h， 生成 1-[1-methyl-6-(4-oxo-1-piperidyl)indazol-3-yl]hexahydropyrimidine-2,4-dione
  参考文献：
  名称：

  [EN] ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
  [FR] COMPOSÉS D'ISOINDOLINONE ET D'INDAZOLE POUR LA DÉGRADATION DE L'EGFR

  摘要：

  这项发明提供了通过泛素化表皮生长因子受体（EGFR）蛋白并随后的蛋白酶体降解来降解EGFR，包括突变形式的化合物。这些化合物对于治疗各种癌症是有用的。

  公开号：

  WO2021127561A1
• 作为产物：
  描述：

  2-氟-4-溴苯腈 、 甲基肼 在 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 150.0 ℃ 、1.72 MPa 条件下， 以62%的产率得到6-溴-1-甲基-1H-吲唑-3-胺
  参考文献：
  名称：

  使用流动反应器的一步一步合成取代的吲唑

  摘要：

  流动化学是医药工业中快速发展的技术，无论是在药物化学领域还是在发展化学领域。流动化学的优点，增加的安全性，改进的可重复性，增强的可扩展性显而易见，我们的目标是利用这一技术，以通过安全且可扩展的途径提供少量可药用的片段，从而实现快速合成。需求量为多克。在这里，我们报告了一种通用且通用的途径，该途径利用流动化学来提供一系列已知的和新颖的吲唑，包括3-氨基和3-羟基类似物。

  DOI：

  10.1021/op100288t

文献信息

• Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19
  作者：Aurélie Mallinger、Kai Schiemann、Christian Rink、Frank Stieber、Michel Calderini、Simon Crumpler、Mark Stubbs、Olajumoke Adeniji-Popoola、Oliver Poeschke、Michael Busch、Paul Czodrowski、Djordje Musil、Daniel Schwarz、Maria-Jesus Ortiz-Ruiz、Richard Schneider、Ching Thai、Melanie Valenti、Alexis de Haven Brandon、Rosemary Burke、Paul Workman、Trevor Dale、Dirk Wienke、Paul A. Clarke、Christina Esdar、Florence I. Raynaud、Suzanne A. Eccles、Felix Rohdich、Julian Blagg

  DOI：10.1021/acs.jmedchem.5b01685

  日期：2016.2.11

  complex-associated cyclin-dependent kinase CDK8 has been implicated in human disease, particularly in colorectal cancer where it has been reported as a putative oncogene. Here we report the discovery of 109 (CCT251921), a potent, selective, and orally bioavailable inhibitor of CDK8 with equipotent affinity for CDK19. We describe a structure-based design approach leading to the discovery of a 3,4,5-trisubstituted-2-aminopyridine

  介体复合物相关的细胞周期蛋白依赖性激酶 CDK8 与人类疾病有关，特别是在结肠直肠癌中，据报道它是一种推定的癌基因。在这里，我们报告了109 (CCT251921) 的发现，它是一种有效的、选择性的和口服生物可利用的 CDK8 抑制剂，对 CDK19 具有等效的亲和力。我们描述了一种基于结构的设计方法，导致发现了 3,4,5-三取代-2-氨基吡啶系列，并介绍了物理化学性质分析的应用，以成功降低体内代谢清除率，最大限度地减少转运蛋白介导的胆汁消除，同时保持可接受的水溶性。化合物109提供了体外生化、药代动力学和物理化学性质的最佳折衷，并适用于发展为癌症动物模型。
• [EN] AMINOINDAZOLE DERIVATIVES AS SODIUM CHANNEL INHIBITORS<br/>[FR] DÉRIVÉS AMINO-INDAZOLES UTILISÉS COMME INHIBITEURS DES CANAUX SODIQUES
  申请人：ALMIRALL SA

  公开号：WO2016150971A1

  公开（公告）日：2016-09-29

  The present invention relates to novel aminoindazolyl derivative compounds of Formula (I), the use of said compounds in treating diseases mediated by modulation of voltage-gated sodium channels in particular Nav1.7, to compositions containing said derivatives and processes for their preparation.

  本发明涉及一种新型氨基吲唑基衍生物化合物（I）的使用，用于治疗特定通过调节电压门控钠通道，尤其是Nav1.7介导的疾病，以及含有这些衍生物的组合物和它们的制备方法。
• [EN] PESTICIDAL COMPOUNDS<br/>[FR] COMPOSÉS PESTICIDES
  申请人：BASF SE

  公开号：WO2018177781A1

  公开（公告）日：2018-10-04

  The present invention relates to the compounds of formula (I), and the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof wherein the variables are defined according to the description, (I). The compounds of formula (I), as well as the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof, are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.

  本发明涉及式(I)的化合物，以及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐，其中变量根据描述(I)中定义。式(I)的化合物以及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐对于对抗或控制无脊椎动物害虫，特别是节肢动物害虫和线虫是有用的。该发明还涉及一种通过使用这些化合物来控制无脊椎动物害虫的方法，以及包括所述化合物的植物繁殖材料和农业和兽医组合物。
• [EN] TARGETED PROTEIN DEGRADATION<br/>[FR] DÉGRADATION CIBLÉE DE PROTÉINES
  申请人：C4 THERAPEUTICS INC

  公开号：WO2020132561A1

  公开（公告）日：2020-06-25

  This invention provides pharmaceutical protein degraders and E3 ubiquitin ligase binders for therapeutic applications as described further herein.

  这项发明提供了用于治疗应用的药用蛋白质降解剂和E3泛素连接酶结合物。
• THERAPEUTIC COMPOUNDS
  申请人：Gilead Sciences, Inc.

  公开号：US20130281433A1

  公开（公告）日：2013-10-24

  Compounds disclosed herein including compounds of formula I′: and salts thereof are provided. Pharmaceutical compositions comprising compounds disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection using compounds disclosed herein are also provided.

  本文披露的化合物包括公式I′的化合物及其盐。还提供了包含本文披露的化合物的药物组合物、制备本文披露的化合物的方法、用于制备本文披露的化合物的中间体以及使用本文披露的化合物治疗HIV感染的治疗方法。